The biochemical parameters of mineral bone disorders including increased fibroblast growth factor 23 (FGF23), hyperphosphatemia, hypocalcemia, elevated parathormone (PTH), and 1,25-dihydroxy vitamin D3 deficiency, were frequently observed in CKD (6). This evidence concerns the gene FGF23 and abnormal mineralization disorder.